SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001561743-17-000043
Filing Date
2017-08-07
Accepted
2017-08-07 16:10:32
Documents
46
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kindred10qq22017.htm 10-Q 638810
2 EXHIBIT 31.1 exhibit311q22017.htm EX-31.1 14029
3 EXHIBIT 31.2 exhibit312q22017.htm EX-31.2 14048
4 EXHIBIT 32.1 exhibit321q22017.htm EX-32.1 8141
  Complete submission text file 0001561743-17-000043.txt   3765454

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT kin-20170630.xml EX-101.INS 869780
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kin-20170630.xsd EX-101.SCH 25713
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kin-20170630_cal.xml EX-101.CAL 48764
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kin-20170630_def.xml EX-101.DEF 132189
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kin-20170630_lab.xml EX-101.LAB 364300
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kin-20170630_pre.xml EX-101.PRE 212770
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36225 | Film No.: 171011594
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1